Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) recorded Net Income towards Common Stockholders of $63.73 million in Q1 2026, up 12.3% from $56.74 million a year earlier and up 20.9% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
On a TTM basis, Catalyst Pharmaceuticals' Net Income towards Common Stockholders came in at $221.32 million as of Mar 31, 2026, up 12.1% year-over-year; for FY2025, it was $214.33 million, up 30.8% from FY2024.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 23.4% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at $163.89 million in FY2024 (+129.5%), $71.41 million in FY2023 (-14.0%), $83.08 million in FY2022 (+110.4%) and $39.48 million in FY2021 (-47.3%).
- The Q1 2026 figure is the highest quarterly Net Income towards Common Stockholders in data going back to Q3 2010.
- On a year-over-year basis, Net Income towards Common Stockholders rose in six of the last seven quarters, with growth averaging 38.1%.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 173.6% in Q4 2022, against a decline of 76.2% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $52.7 million (Q4 2025), $52.78 million (Q3 2025) and $52.11 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 63.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 63.73 Mn |
| Dec 31, 2025 | 52.70 Mn |
| Sep 30, 2025 | 52.78 Mn |
| Jun 30, 2025 | 52.11 Mn |
| Mar 31, 2025 | 56.74 Mn |
| Dec 31, 2024 | 55.94 Mn |
| Sep 30, 2024 | 43.88 Mn |
| Jun 30, 2024 | 40.79 Mn |
| Mar 31, 2024 | 23.28 Mn |
| Dec 31, 2023 | 34.84 Mn |
| Sep 30, 2023 | -30.76 Mn |
| Jun 30, 2023 | 37.76 Mn |
| Mar 31, 2023 | 29.57 Mn |
| Dec 31, 2022 | 25.47 Mn |
| Sep 30, 2022 | 22.75 Mn |
| Jun 30, 2022 | 21.62 Mn |
| Mar 31, 2022 | 13.24 Mn |
| Dec 31, 2021 | 9.31 Mn |
| Sep 30, 2021 | 10.33 Mn |
| Jun 30, 2021 | 12.18 Mn |
API Access
Catalyst Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();